| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0741-5214(94)90230-5 |
| P698 | PubMed publication ID | 7990188 |
| P50 | author | Henk J Blom | Q39861503 |
| P2093 | author name string | van den Berg M | |
| Stehouwer CD | |||
| Jakobs C | |||
| Boers GH | |||
| Rauwerda JA | |||
| Franken DG | |||
| P433 | issue | 6 | |
| P921 | main subject | folic acid | Q127060 |
| vitamin B | Q183206 | ||
| pyridoxine | Q423746 | ||
| vitamin B6 | Q205130 | ||
| P304 | page(s) | 933-940 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Journal of Vascular Surgery | Q15755733 |
| P1476 | title | Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. | |
| P478 | volume | 20 |
| Q33955167 | Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease |
| Q51564032 | Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. |
| Q34109461 | Diagnosis and treatment of hyperhomocysteinemia |
| Q36392251 | Does nutrition have a role in peripheral vascular disease? |
| Q39106654 | Effect of Folic Acid therapy on Homocysteine Level in patients with Atherosclerosis or Buerger's Disease and in Healthy individuals: A clinical trial. |
| Q51564720 | Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. |
| Q44845868 | Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial |
| Q51558185 | Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. |
| Q77093578 | Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction |
| Q44696043 | Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women |
| Q28372338 | Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment |
| Q44724801 | Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels |
| Q36078720 | Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review |
| Q38460537 | Homocysteinemia as a risk factor for atherosclerosis: a review |
| Q36680974 | Homocystinuria: what about mild hyperhomocysteinaemia? |
| Q34435609 | Hyperhomocysteinaemia and associated disease |
| Q50995714 | Hyperhomocysteinaemia is a risk factor for vein graft stenosis. |
| Q34080418 | Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications |
| Q70849441 | Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease |
| Q30802259 | Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data |
| Q33780732 | Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors |
| Q33942497 | Influences of pre- and postnatal nutritional exposures on vascular/endocrine systems in animals |
| Q60662462 | Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration |
| Q44673201 | Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease |
| Q51561691 | Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study. |
| Q56830705 | Nutritional and racial determinants of the increase in plasma homocysteine levels after methionine loading |
| Q35631360 | Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go? |
| Q36177627 | Place of drug therapy in the treatment of carotid stenosis |
| Q56830711 | Plasma homocysteine concentrations in a healthy population living in Burkina Faso |
| Q34706578 | Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens |
| Q34038098 | Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care |
| Q51553967 | The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. |
| Q41521482 | The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia |
| Q33785883 | Total homocysteine and cardiovascular disease |
| Q51569420 | [A young patient with multiple arterial occlusions] |
| Q51556745 | [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype] |
Search more.